Ophthalmology Education and CME

Select a Specialty

J176
CME

Noninfectious Uveitis: Moving Beyond Convention for Long-Term Management

This activity is supported by educational grants from AbbVie, Inc.; Mallinckrodt Pharmaceuticals; and Santen Inc.

Expiration Date: 4/16/2019
Credit Type(s): CME | Credit: 0.75

Noninfectious uveitis is a leading cause of preventable blindness worldwide. To avert potential severe vision loss, a timely diagnosis must be provided, and the…

go to activity»
/sitecore/media library/Images/Education Lab/Top Picks/2018/Ophthalmology/j732_top_pick_280x180
CME

Current Treatment Algorithms for the Management of Dry Eye Disease

This activity is supported by educational grants from Allergan, Inc. and Shire Pharmaceuticals.

Expiration Date: 4/9/2019
Credit Type(s): CME | Credit: 0.25

Dry eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, accompanied by ocular symptoms. This CME activity will…

go to activity»
J894
CME

Improving the Clinical Picture of IOP in Glaucoma Through Innovative Treatments

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 4/8/2019
Credit Type(s): CME | Credit: 0.75

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have…

go to activity»
Dry Eye
CME

Treating Inflammation in Dry Eye: The Rule, Not the Exception

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 4/3/2019
Credit Type(s): CME | Credit: 0.75

Dry eye disease (DED) is one of the most frequently encountered ocular surface disorders. It is a growing public health problem and one of the most common conditions…

go to activity»
Deliver the distance while treating presbyopia

Deliver the Distance While Treating Presbyopia

This activity is produced by SLACK Incorporated and sponsored by Alcon Laboratories, Inc. Participating physicians are paid consultants of Alcon Laboratories, Inc.

March 9, 2018

To help patients meet their postoperative visual goals, patients need to be educated on and paired with an intraocular lens that fits their lifestyle and expectations…

go to activity»
J647
CME

The Coming of Age of Early to Late Age-Related Macular Degeneration: Classification and Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 1/15/2019
Credit Type(s): CME | Credit: 0.75

Geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), affects approximately 5 million individuals worldwide. Advances in predictive and…

go to activity»
Macular Degeneration CME
CME

Advancing Science on Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/25/2019
Credit Type(s): CME | Credit: 1.25

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because age is a major risk factor for developing AMD, it…

go to activity»
J970
CME

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/9/2019
Credit Type(s): CME | Credit: 0.75

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
J987
CME

Providing Defense at the Ocular Surface: Managing Dry Eye

This activity is supported by an educational grant from Shire.

Expiration Date: 4/5/2019
Credit Type(s): CME | Credit: 0.75

This CME activity will discuss modalities for diagnosing ocular surface disease as well as assess the attributes and limitations of using dry eye monotherapy and…

go to activity»
J554_02
CME

MIGS Perspectives with Reay H. Brown, MD

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 3/19/2019
Credit Type(s): CME | Credit: 0.25

Minimally invasive glaucoma surgery (MIGS) is generally safer, with quicker recovery times. This on-the-scene expert interview will describe new advances with MIGS for…

go to activity»
Glaucoma

Because glaucoma typically begins by affecting the far periphery of the vision, most patients are unaware that they have the disease until it progresses and destroys…

go to activity»
cypass stent
CME

Case Presentation: CyPass Stent in the Left Eye and an iStent in the Right Eye

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 1/5/2019
Credit Type(s): CME | Credit: 0.25

In this CME activity, the clinical course of a patient with a CyPass Stent in the left eye and an iStent in the right eye will be described….

go to activity»